A Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study to Assess the Short-Term Effects of PRX-03140 Alone and in Combination With Donepezil in Subjects With Mild Alzheimer's Disease

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study to Assess the Short-Term Effects of PRX-03140 Alone and in Combination With Donepezil in Subjects With Mild Alzheimer's Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Jan 2010

At a glance

  • Drugs Donepezil; PRX 3140
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors EPIX Pharmaceuticals
  • Most Recent Events

    • 17 Jan 2008 Amended results were reported in a EPIX Pharmaceuticals media release.
    • 19 Dec 2007 Status changed from in progress to completed.
    • 19 Dec 2007 Results have been announced in an Epix Pharmaceuticals media release (9083709).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top